AI-generated summary
This Cochrane review searched databases for controlled trials of melatonin or agomelatine for preventing seasonal affective disorder in adults with a history of the condition. The authors report that they found no eligible controlled studies, so no conclusion can be drawn about whether either treatment is effective or ineffective. They call for well-conducted randomised controlled trials.
- Who or what was studied
- Adults with a history of winter-type seasonal affective disorder who were free of symptoms at study start
- Limits stated in the abstract
- No controlled studies were identified, so the evidence base is absent and the review cannot judge efficacy or safety.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on doi.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Randomized controlled trial, Meta-analysis, Risk of bias, Depression, Anxiety. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.